Divi's Laboratories Ltd. (DIVISLAB) Share Price Hits Fresh 52-Week High

Divi's Laboratories Ltd. Share Price stood at Rs 8,633, up 1.12% today, after hitting a fresh 52-week high of Rs 8,670.50. Market capitalisation was Rs 2,19,675.25 crore.

Divi's Laboratories Ltd. Share Price was at Rs 8,633 on 12 August 2026, up Rs 96 or 1.12% from the previous close of Rs 8,537, after the stock touched a fresh 52-week high of Rs 8,670.50. With a market capitalisation of Rs 2,19,675.25 crore, the Healthcare stock has moved into focus in today’s Stock Market Today and Share Market Today discussion as investors track fresh yearly highs and market movers.

The verified data confirms the price event clearly: Divi's Laboratories Ltd. Share Price Today opened at Rs 8,663.85, traded between Rs 8,580.20 and Rs 8,670.50, and generated turnover of Rs 4.87 crore on volume of 5,640 shares. That combination makes this a notable Divi's Laboratories Ltd. Stock News development because a new 52-week peak often brings added attention from traders following price action as well as investors comparing valuation and profitability with sector benchmarks.

The supplied data establishes that the stock is rising and trending because it recorded a fresh one-year high in live trading. It does not establish a company-specific catalyst, so the most relevant next step is to examine the price structure, valuation ratios and Healthcare sector context. In this Univest analysis, the key figures to monitor are the current price, turnover, market cap, P/E ratio of 31.07, P/B ratio of 0.45, ROE of -2.89 and ROCE of -0.26.

Divi's Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 8,633
Previous Close	Rs 8,537
Today's Change	+Rs 96 (+1.12%)
Day Open	Rs 8,663.85
Fresh 52-Week High	Rs 8,670.5
Day Low	Rs 8,580.2
Current Volume	5,640
Turnover	Rs 4.87 crore
Market Capitalisation	Rs 2,19,675.25 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 8,633. versus the previous close of Rs 8,537, a rise of 1.12%. The stock opened at Rs 8,663.85, reached Rs 8,670.5, touched Rs 8,580.2. Reported volume was 5,640.

Divi's Laboratories Ltd. Share Price Today moved into a fresh 52-week high zone, showing that the stock has extended its one-year range despite some intraday pullback from the session top. The day’s range, gain over the previous close and recorded turnover together define what happened in the market today.

On the session tracked by Univest, Divi's Laboratories Ltd. Share Price opened at Rs 8,663.85, which was already above the previous close of Rs 8,537. The stock then hit a fresh 52-week high of Rs 8,670.50 before easing to Rs 8,633. Even after that moderation, the stock remained up Rs 96 for the day, or 1.12%, confirming a positive session.

The intraday low stood at Rs 8,580.20, which means the stock traded in a relatively defined band between Rs 8,580.20 and Rs 8,670.50. That range shows that the fresh 52-week peak was not a marginal tick alone; it came within an active session where buyers were willing to hold the stock above the previous close.

Turnover was Rs 4.87 crore and current volume was 5,640 shares. For investors watching Divi's Laboratories Ltd. Share News and intraday market trends, these numbers confirm actual trading participation behind the move. The stock’s ability to print a new 52-week high while maintaining a positive day change keeps it in focus among 52 Week High Stocks and Stocks in News. The next question is whether the broader financial profile adds enough context to justify continued investor attention.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,19,675.25 crore
P/E Ratio	31.07x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Divi's Laboratories Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.07x
Benchmark Median P/E	21.13x
Benchmark Average P/E	65.01x
Benchmark P/E Range	0x to 3,374.81x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.92%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 2,19,675.25 crore
Benchmark Median Market Cap	Rs 142.81 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,949.87	31.07	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,775.9	71.31	11.28	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,594.65	179.52	3.32	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,561.88	33.61	6.93	-2.6	16.92
NGL Fine-Chem Ltd.	NGLFINE	2,140.53	44.41	6.49	27.9	33.91

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,19,675.25 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories Ltd.

This stock is attracting attention because the verified dataset combines a fresh 52-week peak with an unusual mix of valuation, size and profitability metrics. That makes it relevant for both short-term market trackers and longer-term stock analysis watchers.

• Fresh price event: The stock hit a new 52-week high of Rs 8,670.50 and was still up 1.12% at Rs 8,633.
• Active session data: The stock opened at Rs 8,663.85, traded down to Rs 8,580.20 and recorded Rs 4.87 crore turnover on 5,640 shares.
• Large-cap visibility: Market capitalisation stands at Rs 2,19,675.25 crore, making this a closely watched Healthcare market mover.
• Valuation context: P/E of 31.07 is above the sector median of 21.13 but below the sector average of 65.01, while P/B of 0.45 is below sector benchmarks.
• Profitability check: ROE of -2.89 and ROCE of -0.26 are below the sector median and average, which adds caution to the fundamental picture.

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd. (DIVISLAB) is being tracked in this Univest article as a listed Healthcare sector company. The verified market dataset used here identifies the stock by its exchange symbol DIVISLAB and places it within the Healthcare segment for sector and peer comparison purposes.

In the current Divi's Laboratories Ltd. Company News cycle, the stock is notable because it reached a fresh 52-week high during the session on 12 August 2026. The company is being compared in the same broad sector with Healthcare names such as Dishman Carbogen Amcis Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd., Dr Agarwals Eye Hospital Ltd. and NGL Fine-Chem Ltd. That comparison helps investors place the stock’s valuation and return profile in a wider market context on Univest, even when the immediate event is driven by price action rather than a separately verified corporate update.

Track Divi's Laboratories Ltd. Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Divi's Laboratories Ltd. Share Price Live alongside key market metrics such as the current price, day change, turnover, 52-week levels and market capitalisation. Univest also helps users compare sector benchmarks, valuation ratios and peer data in one place, making it easier to follow Divi's Laboratories Ltd. Share Price Today as part of a broader stock analysis process.

For users monitoring Divi's Laboratories Ltd. NSE and Divi's Laboratories Ltd. BSE search intent, the most useful approach is to watch whether the stock sustains attention after this fresh 52-week high, how the valuation metrics compare with sector averages, and whether peer profitability differences remain material in future updates. Univest keeps that market context organised without turning it into a recommendation.

Frequently Asked Questions

What is the latest Divi's Laboratories Ltd. Share Price today?

Ans. Divi's Laboratories Ltd. Share Price today was Rs 8,633 at the time of this update. The stock was up Rs 96, or 1.12%, from the previous close of Rs 8,537 after touching a fresh 52-week high.

Did Divi's Laboratories Ltd. hit a fresh 52-week high?

Ans. Yes, the stock hit a fresh 52-week high of Rs 8,670.50 during the session. It later traded at Rs 8,633, still holding a positive day change of 1.12% and remaining in focus among today’s market movers.

Why is Divi's Laboratories Ltd. Share Price rising today?

Ans. The supplied data confirms that the stock is rising because it moved to a fresh one-year high and stayed above the previous close. The dataset verifies the price event, turnover of Rs 4.87 crore and active intraday trading range.

What were the day high, day low and opening price?

Ans. The stock opened at Rs 8,663.85, touched a day high of Rs 8,670.50 and fell to a day low of Rs 8,580.20. Those levels frame the session in which the fresh 52-week peak was recorded.

What is the market capitalisation of Divi's Laboratories Ltd.?

Ans. The market capitalisation of Divi's Laboratories Ltd. stood at Rs 2,19,675.25 crore in the supplied dataset. That makes it far larger than the Healthcare benchmark median of Rs 142.81 crore and average of Rs 461.64 crore.

How is Divi's Laboratories Ltd. valued on P/E and P/B?

Ans. The stock is trading at a P/E ratio of 31.07 and a P/B ratio of 0.45. Its P/E is above the Healthcare median of 21.13, while its P/B is below the sector median of 1.9.

What do the ROE and ROCE figures show?

Ans. The supplied fundamentals show ROE of -2.89 and ROCE of -0.26. Both figures are below the Healthcare sector median levels of 10.92 for ROE and 13.29 for ROCE in the benchmark dataset.

How does Divi's Laboratories Ltd. compare with Healthcare peers?

Ans. Compared with supplied peers, the stock’s P/E of 31.07 is below Beta Drugs at 71.31 and Sai Parenteral's at 179.52. However, its ROE and ROCE trail most peers, while market cap is much larger.

What was the trading volume and turnover in this move?

Ans. The stock recorded current volume of 5,640 shares and turnover of Rs 4.87 crore in the tracked session. Those figures confirm real market participation as Divi's Laboratories Ltd. Share Price reached a fresh 52-week high.

What should investors monitor after this 52-week high?

Ans. Investors can monitor whether the stock continues holding above the previous close zone, how valuation compares with Healthcare benchmarks, and whether the gap between low P/B and negative ROE and ROCE remains central to the debate.